SBRA Stock Analysis: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$19.44
-0.17 (-0.87%)
▼
5d:
-1.27%
30d:
-5.4%
90d:
+3.46%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 04, 2026
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SBRA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: SBRA shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$29.38
Based on 8.5% avg growth
INTRINSIC VALUE TODAY
$18.24
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $19.44, which is considered oversold relative to its 30-day fair value range of $19.85 to $20.73. The stock's valuation (Forward PE: 24.8) is in line with its historical norms (25.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $19.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.92 (+12.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $19.46. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $21.92 (+12.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$19.85 -
$20.73
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($21.92)
Fair Price Analysis
30-Day Fair Range
$19.85 -
$20.73
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$19.47
Resistance Level
$20.97
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.76
Wall Street Target
$21.92
(+12.8%)
Revenue Growth (YoY)
15.8%
Earnings Growth (YoY)
-44.7%
Profit Margin
20.1%
Valuation Discount vs History
-1.0% cheaper
PE vs Historical
24.8 vs 25.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.0%
(market-implied from PE analysis)
1-Year Target
$19.25
(-1%)
2-Year Target
$19.05
(-2%)
3-Year Target
$18.86
(-3%)
3-Yr Target (if PE normalizes)
(PE: 25→26)
$19.42
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.8, Growth: 12.9%)
$28.01
(+44%)
Base:
(SPY PE: 22.4, Growth: 12.9%)
$25.28
(+30%)
Bear:
(PE: 19.0, Growth: 12.9%)
$21.49
(+11%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 30.61 | Current EPS (TTM): $0.64
Bull Case
$26.43
(+34%)
Analyst growth 22.7%, PE expands to 33.7
Base Case
$24.03
(+22%)
Market implied 22.7%, PE stable at 30.6
Bear Case
$13.32
(-32%)
Severe decline -20.0%, PE contracts to 26.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.8 to 25.5
Stabilization Target:
$20.02
(+3.0%)
PE Expansion Potential:
+3.0%
Share & Embed Analysis
Last updated: March 31, 2026 3:29 AM ET
Data refreshes hourly during market hours. Next update: 4:29 AM
Data refreshes hourly during market hours. Next update: 4:29 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$92 | 61 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$229 | 53 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$20 | 54 HOLD |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$58 | 59 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 57 HOLD |
